Topical detomidine (Clexio Biosciences)

N/A

Report date: 2025/05/29 16:54:30

Base Information

Drug NameTopical detomidine (Clexio Biosciences)
Drug Alias NameDetomidine hydrochlorideDomosedanCLE-400CLE400
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlpha-2a adrenergic receptor agonists
TargetsAlpha-2a adrenergic receptor
Therapy Area/IndicationsPruritus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesClexio Biosciences Ltd
China Registration ClassN/A

Develop Information

Active CompaniesClexio Biosciences Ltd
Inactive CompaniesN/A
Active IndicationsPruritus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A